Tag : Oncology

Clinical Research, Pharma & Healthcare Financing

Kairos Pharma Signs Term Sheet for Two Oncology Assets

Business Wire
by Business Wire014
Transformative clinical pipeline transaction will add CL-273, a pan-EGFR inhibitor, and CL-741, a Phase 1-Ready c-MET inhibitor, to Kairos Pharma’s clinical portfolio to target multi-billion...